Skip to content

To study the effect of Duralabhadi Churna in vatik kasa(Dry cough)in children

A Single Arm Clinical Study To Evaluate The Efficacy Of Duralabhadi Churna In The Management Of Vatik Kasa In Children. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066800
Enrollment
45
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough Health Condition 2: J00-J99- Diseases of the respiratory system

Interventions

None listed

Sponsors

Dr Rukhsana Sheikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)The patients having minimum 2 symptoms of Vatik Kasa are as follows- 1.The frequency of Kasa vega (Dry Cough) 2.Udarparshwa Shula (chest pain) 3.Swarbheda (Hoarseness of Voice) 4.Shukpurna Galasyata (Feeling Of Thorn Pricking in the Throat) 2) Patients between the ages of 1 year and 12 year. 3) The patients whose parents are ready to participate in the clinical trial by giving informed written consent.

Exclusion criteria

Exclusion criteria: 1)Patients of other types of kasa (pittaj, kaphaj, kshayaj, kshataj) 2)Patients having life threatening illness and who is bed ridden. 3)Patients having any congenital respiratory and GIT abnormality. 4)Patients who require surgical management. 5)Patients having concomitant other systemic disorders like T.B., Bronchiolitis, Asthma, Pneumonia, Bronchiectasis, Lung abscess, Foreign body, pertussis etc. 6)Patient having complaint of fever or recent history of fever .

Design outcomes

Primary

MeasureTime frame
Improvement in swarabheda & kasa vega after taking Duralabhadi Churna in the management of Vatik Kasa. Timepoint: 5 Days study with followup on 3rd and 5th day

Secondary

MeasureTime frame
To study the Adverse effect of Duralabhadi Churna, if anyTimepoint: 5 Days study with followup on 3rd and 5th day (0,3,5 Days)

Countries

India

Contacts

Public ContactDr Rukhsana Sheikh

Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune

dr.mosim2010@gmail.com7350751503

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026